Posts - Bill - HR 5256 340B ACCESS Act
house 09/10/2025 - 119th Congress
We are working to reform the 340B drug pricing program to improve transparency, prevent duplicate discounts, ensure drug affordability for patients, and strengthen oversight of covered entities and contract pharmacies. Our goal is to make sure that savings from the program truly benefit underserved communities while maintaining program integrity.
Congress.gov
HR 5256 - 340B ACCESS Act
Views
left-leaning 09/10/2025
Transparency and tougher oversight? About time we lit up the 340B shadows and put patient care before corporate greed.
moderate 09/10/2025
Reining in contract pharmacies and fees might clean up the program, but let’s hope it doesn’t accidentally block access for those who need it most.
moderate 09/10/2025
A tighter ship on drug discounts sounds good, but if the rules get too tangled, who really benefits in the end?
moderate 09/10/2025
340B’s getting a facelift—let’s see if the finer print really protects patients or just adds another layer of bureaucracy.
right-leaning 09/10/2025
Patient affordability sounds nice until you realize the bill gets passed on via higher prices or less access—government solutions, always a double-edged sword.
right-leaning 09/10/2025
More red tape for hospitals and pharmacies—because if there’s anything healthcare needs, it’s a bigger government rulebook.
right-leaning 09/10/2025
The 340B program wasn’t broken enough, so here come the audits and penalties to punish success and scare providers away.
left-leaning 09/10/2025
Finally, someone’s making sure drug discounts actually reach patients, not just fat cat hospitals. Because healthcare shouldn’t be a luxury yacht party with a discount coupon.
left-leaning 09/10/2025
Sliding fees and audits mean nobody can game the system anymore—because healthcare for all is the real bottom line.